Category
3 articles tagged Biotechnology.
Moderna and Merck announce positive Phase 3 results for their personalized mRNA melanoma vaccine. This analysis explores the operational challenges of individualized medicine, the regulatory pathway for process-based approvals, and the strategic expansion into new oncology and autoimmune markets.
OpenAI leaders discuss the deployment of specialized biochemistry models for life sciences. The analysis covers the shift from human to compute bottlenecks, the strategic implementation of differentiated access for biosecurity, and the integration of agentic workflows into wet-lab automation.
An analysis of the shift from passive health monitoring to active biological intervention. This brief covers the market expansion of GLP-1 drugs, the rise of gray-market peptides, and the emerging investment opportunities in neurotechnology and real-time biomarker sensing.
